CEREVEL THERAPEUTICS HLDNG I's ticker is CERE and the CUSIP is 15678U128. A total of 123 filers reported holding CEREVEL THERAPEUTICS HLDNG I in Q3 2023. The put-call ratio across all filers is 1.64 and the average weighting 0.6%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BAIN CAPITAL INVESTORS LLC | 60,199,729 | $1,314,160,084 | 42.08% |
| Perceptive Advisors | 10,088,385 | $220,229,445 | 7.35% |
| Finepoint Capital LP | 563,345 | $12,297,821 | 6.12% |
| Affinity Asset Advisors, LLC | 685,061 | $14,954,882 | 4.21% |
| Paradigm Biocapital Advisors LP | 2,532,972 | $55,294,779 | 3.75% |
| Logos Global Management LP | 700,000 | $15,281,000 | 2.04% |
| Artal Group S.A. | 1,638,858 | $35,776 | 1.53% |
| Rock Springs Capital Management LP | 2,529,116 | $55,210,602 | 1.48% |
| GREAT POINT PARTNERS LLC | 215,000 | $4,693,450 | 0.86% |
| Frazier Life Sciences Management, L.P. | 393,000 | $8,579,190 | 0.57% |
| Avidity Partners Management LP | 643,000 | $14,036,690 | 0.56% |
| DAFNA Capital Management LLC | 62,200 | $1,357,826 | 0.42% |
| Avoro Capital Advisors LLC | 955,555 | $20,859,766 | 0.32% |
| HighVista Strategies LLC | 24,887 | $543,283 | 0.25% |
| Eventide Asset Management | 490,000 | $10,696,700 | 0.19% |
| WESTFIELD CAPITAL MANAGEMENT CO LP | 974,483 | $21,272,964 | 0.14% |
| Woodline Partners LP | 476,634 | $10,404,920 | 0.12% |
| Edgestream Partners, L.P. | 65,125 | $1,421,679 | 0.11% |
| LAKE STREET ADVISORS GROUP, LLC | 83,857 | $1,831,000 | 0.11% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 1,505,976 | $32,875,456 | 0.08% |
External links
This page lists CEREVEL THERAPEUTICS HLDNG I's shareholders in Q3 2023. To view CEREVEL THERAPEUTICS HLDNG I's shareholder history, click here.